Lessons in Laboratory Compliance from a $30 Million Settlement
‘Lean lab’ setup appears to have caught the eyes of investigators
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
‘Lean lab’ setup appears to have caught the eyes of investigators
After an eventful month in the Illumina-GRAIL saga, the story may soon be over.
The national retailer recently signed a deal with Simple HealthKit to provide Walmart customers online access to at-home diagnostic test kits.
Gather Labs founder and CEO Rachael McCrary discusses how her lab has achieved success beyond COVID-19 testing.
Recent survey provides insight into how current pressures are impacting laboratory staff wages and compensation.
Yet, despite these declines, Q1 was neither as bad as expected nor totally devoid of positive signs for the future.
What should pathology groups and labs do in order to attract and maintain clinical talent in today’s economy?
After a significant lull, M&As in the lab diagnostics space heated up in May, with several key deals announced.
So far, it appears many post-PHE COVID-19 tests will be panels for detecting and differentiating among multiple respiratory viruses.
A recent report offers new insight into bankruptcy trends within the sector starting before the COVID-19 pandemic.
In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.